Invasive fungal infections represent a global health threat. They are associated with high
mortality and morbidity rates, partly due to the ineffectiveness of the available antifungal …

The introduction of antifungals in clinical practice has an enormous impact on the provision
of medical care, increasing the expectancy and quality of life mainly of immunocompromised …

A total of 51 sponges (Porifera) and 13 ascidians (Chordata) were collected on the coast of
the Yucatan Peninsula (Mexico) and extracted with organic solvents. The resulting extracts …

Candida spp. are common opportunistic microorganisms in the human body and can cause
mucosal, cutaneous, and systemic infections, mainly in individuals with weakened immune …

Candida albicans is still the major yeast causing human fungal infections. Nevertheless, in
the last decades, non-Candida albicans Candida species (NCACs)(eg, Candida glabrata …

Novel anticandidal drugs are urgently required due to the inefficiency of currently existing
pharmacological treatments and the evolution of progressively resistant Candida strains …

The opportunistic yeast pathogen Candida albicans and the emerging non‐albicans
Candida spp. cause life‐threatening infections in immuno‐compromised patients, leading to …

In the last three decades, invasive fungal infections caused by Candida species have
become an important public health problem, because they are associated with high rates of …

Marine sponges and their associated bacteria have been proven to be a rich source of novel
secondary metabolites with therapeutic usefulness in cancer, infection, and autoimmunity. In …

Fungal diseases represent an increasing threat to human health worldwide which in some
cases might be associated with substantial morbidity and mortality. However, only few …